FDA Inspection
Tennessee Reproductive MedicineTennessee Reproductive Medicine – FDA Inspection, Dec 5, 2023
Record Details
This FDA Inspection record concerns Tennessee Reproductive Medicine, with an inspection on December 5, 2023, issued by the Center for Biologics Evaluation and Research, covering biologics.
View Company Profile
ID · 681f13c1-006b-493d-a9d4-b3f2c4bfc027
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 1224648
- FDA center
- Biologics
- Project area
- Blood and Blood Products
Other FDA inspections of Tennessee Reproductive Medicine
5| Date | Classification | Office | Project area |
|---|---|---|---|
| August 4, 2022 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| September 11, 2018 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| February 10, 2016 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| May 28, 2014 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| October 31, 2012 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
Other documents for Tennessee Reproductive Medicine
- FDA Inspection 1176463 - 2022-08-04
- FDA Inspection 1065574 - 2018-09-11
- FDA Inspection 960961 - 2016-02-10
- FDA Inspection 880769 - 2014-05-28
- FDA Inspection 805705 - 2012-10-31
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.